What indicators would you like to setup a trade for?

Candlestick Daily volume index Bar reversal Edit

Trade setup

Position Order Entry Exit Stop Loss Risk Return Expectancy
Long 10 4.5 20% 25% 1.6% -0.8% -3.4%
Short 5 4.2 40% 67% 1.9% -3.2% -5.9%

What indicators would you like to backtest?

Candlestick Daily volume index Bar reversal Edit

Backtest results

Position Trades Duration Win rate Win/loss Avg win Avg loss Return
Long 10 4.5 20% 25% 1.6% -0.8% -3.4%
Short 5 4.2 40% 67% 1.9% -3.2% -5.9%

Company

Indicator

Code Company Date Close Change Indicator Value Signal

Trading Performance

Bar Reversal

Score

-0.55

Position Trades Duration Win Rate Win/Loss Avg Win Avg Loss Return
LONG 34 8.9 0.41% 0.64% 16.3% -4.1% 138.8%
SHORT 34 14.3 0.41% 0.67% 4.5% -6.9% -80.9%

Summary

Technical Analysis

Opthea (OPT.AX)


Indicator:

BAR REVERSAL


Last Signal:

NEUTRAL


Trading: NO POSITION @ $3.02
Signal Strength: MEDIUM
Recommendation:

Indicator can be used in isolation but is strengthened by additional indicator confirmation. Indicator can be applied to the short or medium term timeframe and is able to highlight a potential change in price direction. This bar analysis can provide guidance on the daily battle between sellers and buyers from the companies recent trading.


Opthea (ASX:OPT)No bar reversal is present for Opthea. Over the last 12 months there have been 6 occurrences of no bar reversals giving a signal probability of 2.3%.


PROFILE: Opthea (OPT.AX)


Stock Exchange: ASX
Company: Opthea
Ticker Codes: | OPT.AX | ASX:OPT |

About Opthea (ASX:OPT):

Opthea Limited develops and commercializes therapies primarily for eye disease in Australia. The company's development activities are based on the intellectual property portfolio covering Vascular Endothelial Growth Factors (VEGF) C and D, and VEGF Receptor-3 for the treatment of diseases associated with blood and lymphatic vessel growth, as well as vascular leakage. Its lead molecule is OPT-302, a soluble form of VEGFR-3, which is in Phase 1/2A clinical trial for the treatment of back of the eye diseases, such as wet age-related macular degeneration that is the cause of blindness in elderly and diabetic populations. The company was formerly known as Circadian Technologies Limited and changed its name to Opthea Limited in December 2015. Opthea Limited is based in South Yarra, Australia.

Top 10:

Bar Reversal

Download
Company Close Change(%) Volume Value Signal
BEE Broo 0.02 9.1 493,100 0 NEUTRAL
VOC Vocus Communications 3.2 8.1 5,453,355 0 NEUTRAL
MCP Mcphersons 2.85 6.7 777,047 0 NEUTRAL
ORE Orocobre 3.4 6.6 5,681,011 0 NEUTRAL
IPD Impedimed 0.17 6.5 264,442 0 NEUTRAL
FNP Freedom Nutritional Products 4.95 5.5 527,076 0 NEUTRAL
MYR Myer 0.5 5.3 1,614,004 0 NEUTRAL
CVW Clearview Wealth 0.51 5.2 34,015 0 NEUTRAL
OCL Objective Corporation 6.1 5.2 45,754 0 NEUTRAL
QUB Qube Logistics 3.56 5 2,738,455 0 NEUTRAL